TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RCUS

Arcus Biosciences Inc

Healthcare · Biotechnology

25.20$ -1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -482 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RCUS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13 -25 -43 -73 111 -256 438 -306 -170 -482
1.3 2.6 3.7 3.6 4.2 4.0 6.0 8.0 10 10
0.1 0.5 3.9 9.0 22 55 65 73 76 60
0.1 0.8 3.4 10 22 55 76
3.6 25 1.3 0.1 208 -376 623 -71 22 -194
4.1 5.5 3.7 1.9 3.1 26 6.0 24 6.0 2.0
-39 -49 -113 59 -434 -3.9 -413 194 -84 66
5.0
70 108 125 -0.1 -0.1 0.0 0.0
0.0 0.0 47 49
70 107 129 1.1 439 237 33 33 277 488
18 33 -27 -13 115 -26 58 -79 23 72
-17 -31 -47 -75 108 -282 432 -330 -176 -484

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?